Homocysteine levels in patients with Behçet's disease and patients with recurrent aphthous stomatitis

Clinical Rheumatology

Volumn 28, Issue 10, 2009, Pages 1153-1156

  Gönül, Müzeyyen ^a,c   Gül, Ülker ^a   Kilinç, Cumhur ^b   Çakmak, Seray Külcü ^a   Soylu, Seçil ^a   Kiliç, Arzu ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MEMORIAL HOSPITAL   (Turkey)

^c Bariş Mah Güzelyaka Cad ^*  (Turkey)

Author keywords

Beh et's disease; Folic acid; Homocysteine; Recurrent aphthous stomatitis; Vitamin B12

Indexed keywords

COLCHICINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AMINO ACID BLOOD LEVEL; APHTHOUS STOMATITIS; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SEX DIFFERENCE; SKIN MANIFESTATION;

ADOLESCENT; ADULT; BEHCET SYNDROME; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; STOMATITIS, APHTHOUS; VITAMIN B 12; YOUNG ADULT;

EID: 69949164148     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1214-z     Document Type: Article

References (20)

1. Ateş A, Aydintuǧ O, Ölmez Ü, Düzgün N, Duman M (2005) Serum homocysteine level is higher in Behçet's disease with vascular involvement. Rheumatol Int 25:42-44
2. Sarican T, Ayabakan H, Turkmen S, Kalaslioglu V, Baran F, Yenice N (2007) Homocysteine: An activity marker in Behçet's disease? J Dermatol Sci 45:121-126
3. International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
4. Koybasi S, Parlak AH, Serin E, Yilmaz F, Serin D (2006) Recurrent aphthous stomatitis: Investigation of etiologic factors. Am J Otolaryngol 27:229-232
5. Ghate JV, Jorizzo JL (1999) Behçet's disease and complex aphthosis. J Am Acad Dermatol 40:1-4
6. Özkan Y, Yardim-Akaydin S, Sepici A, Engin B, Sepici V, Şimşek B (2007) Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease. Clin Chem Lab Med 45:73-77
7. Aksu K, Turgan N, Oksel F, Keser G, Özmen D, Kitapçioǧlu G, Gümüşdiş G, Bayindir O, Doǧanavşargil E (2001) Hyperhomocysteinaemia in Behçet's disease. Rheumatology 40:687-690
8. Hermann W (2001) The importance of hyperhomocysteinaemia as a risk factor for diseases: An overwiev. Clin Chem Lab Med 39:666-674
9. Mungan AG, Can M, Açikgöz S, Eştürk E, Altinyazar C (2006) Lipid peroxidation and homocysteine levels in Behçet's disease. Clin Chem Lab Med 44:1115-1118
10. Houman H, Feki M, Ghorbel IB, Gadhoum H, Hsairi M, Omar S, Lamloum M, Kaabachi N, Mebazaa A, Miled M (2003) Does hyperhomocysteinaemia increase the risk of thrombosis in Behçet's disease? Adv Exp Med Biol 528:413-417
11. Lee YJ, Kang SK, Yang JI, Choi YM, Sheen D, Lee EB, Choi SW, Song YW (2002) Coagulation parameters and plasma total homocysteine levels in Behçet's disease. Thromb Res 106:19-24
12. Feki M, Houman H, Ghannouchi M, Smiti-Khanfir M, Hamzaoui K, Matri LE, Mebazaa A, Kaabachi N (2004) Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behçet's disease. Clin Chem Lab Med 42:1417-1423
13. Korkmaz C, Bozan B, Kosar M, Sahin F, Gülbas Z (2002) Is there an association of plasma homocysteine levels with vascular involvement in patients with Behçet's syndrome? Clin Exp Rheumatol 20:S30-S34
14. Ricart JM, Vaya A, Todoli J, Calvo J, Villa P, Estellés A, España F, Sataolaria M, Corella D, Aznar J (2006) Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events. Thromb Haemost 95:618-624
15. Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial fuction and oxydative stress mechanisms in patients with Behçet's syndrome. Am J Coll Cardiol 37:517-520
16. Baykal Y, Özet G, Kocabalkan F (1999) Venöz tromboz ile iliçkili risk faktörleri. Turkiye Klinikleri J Med Sci 19:236-241
17. Er H, Evereklioglu C, Cumurcu T, Türköz Y, Özerol E, Şahin K, Doganay S (2002) Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease. Br J Ophthalmol 86:653-657
18. Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuyudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behçet syndrome: A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 82:60-76
19. Yesilova Z, Pay S, Oktenli C, Musabak U, Saglam K, Sanioglu SY, Dagalp K, Erbil MK, Kocar IH (2005) Hyperhomocysteinemia in patients with Behçet's disease: Is it due to inflammation or therapy. Rheumatol Int 25:423-428
20. Alpsoy E, Zouboulis CC, Ehrlich GE (2007) Mucocutaneous lesions of Behçet's disease. Yonsei Med J 48:573-585